According to the Zhitong Finance App, Kaituo Pharmaceutical-B (09939.HK) announced interim results up to 2026. Revenue increased from 6 million yuan in the same period last year to 52 million yuan for the six months ending June 30, 2026, with a net loss of 75.782 million yuan, a year-on-year decrease of 8.99%; loss per share was 0.15 yuan.

Zhitongcaijing · 1d ago
According to the Zhitong Finance App, Kaituo Pharmaceutical-B (09939.HK) announced interim results up to 2026. Revenue increased from 6 million yuan in the same period last year to 52 million yuan for the six months ending June 30, 2026, with a net loss of 75.782 million yuan, a year-on-year decrease of 8.99%; loss per share was 0.15 yuan.